Your browser doesn't support javascript.
loading
Assessment of anti-streptokinase antibody in patients with heart diseases and normal subjects
IJI-Iranian Journal of Immunology. 2004; 1 (1): 63-70
Dans Anglais | IMEMR | ID: emr-174286
ABSTRACT

Background:

Streptokinase, which is injected intravenously with a standard dose of 1.5 MIU, is the most widely used thrombolytic agent around the world. What is so important about this bioproduct is the level of anti-streptokinase [anti-sk] antibody in the population, which is directly correlated to the incidence of streptococcal infections in that population
Recherche sur Google
Indice: Méditerranée orientale langue: Anglais Texte intégral: Iran. J. Immunol. Année: 2004

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS

Recherche sur Google
Indice: Méditerranée orientale langue: Anglais Texte intégral: Iran. J. Immunol. Année: 2004